ABSTRACT
Epidermal growth factor receptor (EGFR) plays an important role in the development and occurrence of a variety of malignant tumors. Molecular targeted therapy for EGFR is in the ascendant. Molecular imaging can reveal the expression of EGFR and its mutations in vivo. The molecular probes labeled with 89Zr, 11C and 18F are used for imaging and the main research is about tyrosine kinase inhibitors labeled with 11C. PET is used to visualize EGFR expression and mutations in vivo, which can noninvasively screen patients suitable for targeting treatment and evaluate efficacy. This paper reviews the clinical researches and trials of these probes, and summarizes the clinical value of imaging methods, hoping to provide the evidence for clinical translation and application in the future.
ABSTRACT
Objective:To explore the role of clinical pharmacists in the development of individualized drug treatment regimen for multiple myeloma patients with venous thromboembolism. Methods:One multiple myeloma patient suffering from venous thromboembo-lism after being treated with thalidomide combined with pegylated liposomal doxorubicinand dexamethasone was selected as the exam-ple. The cause and treatment of venous thromboembolism and the pharmaceutical service were analyzed. Results: With the help of clinical pharmacists, the patient conquered the chemotherapy-induced venous thromboembolism, and clinical pharmacists enhanced the awareness of pharmaceutical care and played a positive role in the safe and effective drug use. Conclusion: The optimization of drug therapy with the help of clinical pharmacists can improve clinical curative effect and safety of drug treatment.